MB "Biotechnologinių tyrimų centras" Finance - revenue, profit
EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimited| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 79,970 |
| 26,657 |
| 6,093 |
| 5,814 |
| 1,938 |
| 19.52 |
| 7.27 |
| 7,179 |
| 3,655 |
| 3,032 |
| 7,802 |
| 2024 |
|---|
| 51,297 |
| - |
| 3,828 |
| 3,715 |
| - |
| 16.46 |
| 7.24 |
| 10,894 |
| 10,174 |
| 2,813 |
| 18,255 |
| 2025 |
|---|
| 96,987 |
| - |
| -45 |
| -45 |
| - |
| 24.43 |
| -0.05 |
| 10,849 |
| 97 |
| 91 |
| 10,855 |
Enjoy unlimited use
with Freemium unlimited| 2025 |
|---|
| 96,987 |
| - |
| -45 |
| -45 |
| - |
| 24.43 |
| -0.05 |
| 10,849 |
| 97 |
| 91 |
| 10,855 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2025
Turnover (€)
96,987 €89 % *
Sales per employee (€)
-Profit before tax (€)
-45 €-101 % *
Net Profit (€)
-45 €-101 % *
Profit per employee (€)
-Total profitability (%)
24.43 %48.42 % *
Net profitability (%)
-0.05 %-100.69 % *
Equity (€)
10,849 €0 % *
Amounts Payable And Liabilities (€)
97 €-99 % *
Non-current Assets (€)
91 €-97 % *
CurrentAssets (€)
10,855 €-41 % *
